| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The lancet 396 (10258), 1204-1222, 2020 | 13402 | 2020 |
| Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study GA Roth, GA Mensah, CO Johnson, G Addolorato, E Ammirati, ... Journal of the American college of cardiology 76 (25), 2982-3021, 2020 | 12556 | 2020 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 9577 | 2020 |
| Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 821 | 2020 |
| Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 F Farzadfar, M Naghavi, SG Sepanlou, SS Moghaddam, WJ Dangel, ... The Lancet 399 (10335), 1625-1645, 2022 | 252 | 2022 |
| Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia: an 8-week, randomized, double-blind, placebo-controlled study A Modabbernia, F Rezaei, B Salehi, M Jafarinia, M Ashrafi, M Tabrizi, ... CNS drugs 27 (1), 57-65, 2013 | 141 | 2013 |
| Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study MR Khodaie-Ardakani, O Mirshafiee, M Farokhnia, M Tajdini, ... Psychiatry research 215 (3), 540-546, 2014 | 121 | 2014 |
| Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial N Askari, M Moin, M Sanati, M Tajdini, SMR Hosseini, A Modabbernia, ... CNS drugs 26 (10), 883-892, 2012 | 85 | 2012 |
| A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia M Noroozian, S Ghasemi, SMR Hosseini, A Modabbernia, ... Psychopharmacology 228 (4), 595-602, 2013 | 52 | 2013 |
| Cost-effectiveness analysis of PCSK9 inhibitors in cardiovascular diseases: a systematic review S Azari, A Rezapour, N Omidi, V Alipour, M Behzadifar, H Safari, M Tajdini, ... Heart Failure Reviews 25 (6), 1077-1088, 2020 | 46 | 2020 |
| Age and gender differences of basic electrocardiographic values and abnormalities in the general adult population; Tehran Cohort Study P Ahmadi, A Afzalian, A Jalali, S Sadeghian, F Masoudkabir, A Oraii, ... BMC Cardiovascular Disorders 23 (1), 303, 2023 | 37 | 2023 |
| Can respirator face masks in a developing country reduce exposure to ambient particulate matter? S Faridi, RN Nodehi, S Sadeghian, M Tajdini, M Hoseini, M Yunesian, ... Journal of Exposure Science & Environmental Epidemiology 30 (4), 606-617, 2020 | 37 | 2020 |
| Association of serum gamma-glutamyltransferase and premature coronary artery disease AA M. Sheikh, M. Tajdini, A. Shafiee, M. Sotoudeh Anvari, A. Jalali, H ... Netherlands Heart Journal 25 (7), 439_445, 2017 | 33 | 2017 |
| Salivary B-type natriuretic peptide: a new method for heart failure diagnosis and follow up A Joharimoghadam, M Tajdini, A Bozorgi Kardiologia polska 75 (1), 71-77, 2017 | 32 | 2017 |
| Preprocedural colchicine in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a randomized controlled trial (PodCAST-PCI) SH Hosseini, AH Talasaz, M Alidoosti, M Tajdini, BW Van Tassell, ... Journal of Cardiovascular Pharmacology 80 (4), 592-599, 2022 | 30 | 2022 |
| Hospitalization, major complications and mortality in acute myocardial infarction patients during the COVID-19 era: A systematic review and meta-analysis H Pourasghari, H Tavolinejad, S Soleimanpour, Z Abdi, J Arabloo, ... IJC Heart & Vasculature 41, 101058, 2022 | 28 | 2022 |
| Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial SMR Hosseini, M Farokhnia, F Rezaei, A Gougol, H Yekehtaz, N Iranpour, ... European Neuropsychopharmacology 24 (6), 846-855, 2014 | 27 | 2014 |
| Should we think of Urbach–Wiethe disease in refractory epilepsy? Case report and review of the literature HG Omrani, M Tajdini, B Ghelichnia, SMR Hosseini, A Tafakhori, ... Journal of the neurological sciences 320 (1-2), 149-152, 2012 | 25 | 2012 |
| A systematic review of the cost-effectiveness of heart valve replacement with a mechanical versus biological prosthesis in patients with heart valvular disease S Azari, A Rezapour, N Omidi, V Alipour, M Tajdini, S Sadeghian, ... Heart Failure Reviews 25 (3), 495-503, 2020 | 22 | 2020 |
| Mid-term outcomes of off-pump versus on-pump coronary artery bypass graft surgery; statistical challenges in comparison A Sheikhy, A Fallahzadeh, S Sadeghian, K Forouzannia, J Bagheri, ... BMC Cardiovascular Disorders 21 (1), 412, 2021 | 21 | 2021 |
Arash JalaliTehran Heart Center, Cardiovascular Diseases Research Institute,Tehran University of MedicalVerified email at tums.ac.ir
